SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-044427
Filing Date
2019-09-12
Accepted
2019-09-12 16:41:57
Documents
2
Period of Report
2019-09-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv529297_3.html 3  
1 OWNERSHIP DOCUMENT tv529297_3.xml 3 7079
2 EXHIBIT 24 tv529297_ex24.htm EX-24 7614
  Complete submission text file 0001144204-19-044427.txt   16093
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39044 | Film No.: 191090767

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Issuer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences